Results 201 to 210 of about 58,239 (290)

Uveítis recurrente equina [PDF]

, 2004
Gustavo Zapata
openalex  

Seroprevalence of equine leptospirosis in Poland (2019–2023)

Equine Veterinary Journal, Volume 58, Issue 2, Page 523-532, March 2026.
Abstract Background Leptospirosis in horses is associated with various clinical signs, potentially leading to fatal outcomes. Additionally, the disease may pose a zoonotic risk to individuals involved in handling infected animals. Implementing a serological monitoring programme in the equine population is one of the key tools used to reduce the risk of
Jacek Żmudzki, Monika Ostrowska, Zbigniew Arent, Maciej Frant, Maciej Kochanowski, Agnieszka Nowak, Sylwia Zębek, Damian Kalinowski, Katarzyna Podgórska   +8 more
wiley   +1 more source

Beyond the joints: mechanistic insights and multidisciplinary strategies for spondyloarthritis-associated uveitis. [PDF]

Front Immunol
Pan S, Xiang L, Cao Z, Yang Z, Cheng RJ.
europepmc   +1 more source

Uveítis como manifestación secundaria a infecciones de la cavidad bucal. Revisión de la literatura

, 2012
José María González Hernández, Yurilú Andreina González-Moret, Y. Ortiz Martínez, Rosemilia Hernández, Gisselle Fariñas, M. Sambrano   +5 more
openalex   +1 more source

Diagnóstico ecográfico de uveítis anterior en atención primaria

Luis Ortiz-González, Carlos Ortiz-Peces, Violeta Calle-Guisado, Luis Ortiz-Peces   +3 more
openalex   +1 more source

Chronic hepatitis in horses with persistent equine hepacivirus infection

Equine Veterinary Journal, Volume 58, Issue 2, Page 444-457, March 2026.
Abstract Background Equine hepacivirus (EqHV) is closely related to hepatitis C virus (HCV), which causes persistent infection and chronic hepatitis in people. Information on persistent EqHV infection and hepatitis is limited. Objectives To report 19 cases of chronic hepatitis and persistent EqHV infection.
Mason C. Jager, Daniela Luethy, Samantha Shallop, Jessica Cathcart, Thomas J. Divers, Jean‐Yin Tan, Erin McConachie Beasley, Philip Johnson, Laurence Leduc, Claire Smith, Camilla Anne Jamieson, K. Gary Magdesian, Gerlinde R. Van de Walle, Joy E. Tomlinson   +13 more
wiley   +1 more source

Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies. [PDF]

Front Oncol
Aqil MS, Al-Marrawi Y, Yaldo M, Abu-Mahfouz A, Singh L, Gopishetty S, Idogun P, Ezekwudo D, Jaiyesimi I, Weiner AJ.   +9 more
europepmc   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

Retrospective Case Series of Ocular Lyme Disease, 1988-2025. [PDF]

Emerg Infect Dis
Bellafiore J, Mahrous A, Gurumurthy V, Capitle E, Schutzer SE.   +4 more
europepmc   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source